BACKGROUND:Forskolin,a diterpenoid natural compound extracted from Coleus forskohlii,has a crucial regulatory role in skeletal muscle repair.However,the regulatory role of forskolin on myogenic differentiation of C2C12 skeletal muscle cells has not been fully explored.OBJECTIVE:To explore the effects of forskolin on the differentiation of C2C12 myoblast cell line and probe into the underlying molecular mechanisms.METHODS:C2C12 cells were treated with 0,0.1,0.25,0.5,1,5,10 and 20 μmol/L forskolin during growth,and cell proliferation was detected by cell counting kit-8 and qRT-PCR.C2C12 cells were treated with 0,0.25,0.5 and 1 μmol/L forskolin during the induction of myogenic differentiation.Immunofluorescence staining and qRT-PCR were used to detect C2C12 cells differentiation.Western blot was used to detect the expression level of myogenic differentiation-related signaling pathway proteins.RESULTS AND CONCLUSION:(1)The viability of C2C12 cells was decreased and cell proliferation was inhibited after treatment with high concentrations(＞1 μmol/L)of forskolin.(2)The qRT-PCR results showed that forskolin up-regulated the expression of Myh2,Myh4,Myomaker,but down-regulated the expression of Myh7 compared with the 0 μmol/L group,when C2C12 cells were differentiated for 4 days.Immunofluorescence staining results showed that the fusion index and myotube diameter of C2C12 cells were increased after forskolin treatment,and the number of myotubes was also increased.(3)Western blot results showed that the phosphorylated extracellular signal-regulated kinase 1/2 expression was inhibited;however,the phosphorylated protein kinase B was promoted after treatment with forskolin.The protein expression level of the myogenic differentiation transcription factor Myogenin was significantly up-regulated after treatment with forskolin.The above results demonstrate that forskolin may promote myogenic differentiation of C2C12 skeletal muscle cells through the extracellular signal-regulated kinase 1/2 and protein kinase B signaling pathway.

BACKGROUND:Forskolin,a diterpenoid natural compound extracted from Coleus forskohlii,has a crucial regulatory role in skeletal muscle repair.However,the regulatory role of forskolin on myogenic differentiation of C2C12 skeletal muscle cells has not been fully explored.OBJECTIVE:To explore the effects of forskolin on the differentiation of C2C12 myoblast cell line and probe into the underlying molecular mechanisms.METHODS:C2C12 cells were treated with 0,0.1,0.25,0.5,1,5,10 and 20 μmol/L forskolin during growth,and cell proliferation was detected by cell counting kit-8 and qRT-PCR.C2C12 cells were treated with 0,0.25,0.5 and 1 μmol/L forskolin during the induction of myogenic differentiation.Immunofluorescence staining and qRT-PCR were used to detect C2C12 cells differentiation.Western blot was used to detect the expression level of myogenic differentiation-related signaling pathway proteins.RESULTS AND CONCLUSION:(1)The viability of C2C12 cells was decreased and cell proliferation was inhibited after treatment with high concentrations(＞1 μmol/L)of forskolin.(2)The qRT-PCR results showed that forskolin up-regulated the expression of Myh2,Myh4,Myomaker,but down-regulated the expression of Myh7 compared with the 0 μmol/L group,when C2C12 cells were differentiated for 4 days.Immunofluorescence staining results showed that the fusion index and myotube diameter of C2C12 cells were increased after forskolin treatment,and the number of myotubes was also increased.(3)Western blot results showed that the phosphorylated extracellular signal-regulated kinase 1/2 expression was inhibited;however,the phosphorylated protein kinase B was promoted after treatment with forskolin.The protein expression level of the myogenic differentiation transcription factor Myogenin was significantly up-regulated after treatment with forskolin.The above results demonstrate that forskolin may promote myogenic differentiation of C2C12 skeletal muscle cells through the extracellular signal-regulated kinase 1/2 and protein kinase B signaling pathway.

With the continuous deepening of the concept of precision diagnosis and treatment for lung cancer, how to achieve higher efficiency and accuracy in the screening, diagnosis, and treatment pathways in clinical practice has become an important issue that urgently needs to be overcome. The current clinical difficulty lies in the fact that despite continuous advancements in imaging and molecular diagnostic technologies, there are still limitations in manual efficiency and subjective experience when it comes to massive data analysis and multi-scale feature extraction. Artificial intelligence (AI), especially algorithm systems based on deep learning, is an innovative technology capable of deeply empowering medical big data. This method utilizes algorithms such as convolutional neural networks, combined with radiomics, pathomics, and multi-modal data fusion analysis, demonstrating immense potential in early precise detection and benign-malignant differentiation of pulmonary nodules, digital pathological subtype recognition and non-invasive prediction of driver genes, precise 3D surgical planning and automatic delineation of radiotherapy target volumes, as well as dynamic risk warning during follow-up. This innovative technology provides a brand-new solution for realizing intelligent and individualized lung cancer diagnosis and treatment models. This consensus, based on the latest evidence from evidence-based medicine and combined with the development trends in the AI field and real-world clinical needs, was ultimately formed by gathering the consensus opinions of multidisciplinary experts in radiology, pathology, thoracic surgery, and other fields. The main content covers the application specifications of AI in the three core scenarios of lung cancer screening, diagnosis, and treatment, the technical standards for data collection and algorithm validation, as well as the ethical and regulatory challenges faced at the current stage. It aims to clarify the applicable boundaries of AI as a clinical auxiliary decision support tool, providing scientific guidance and standardized exploration directions for peers currently engaged in or planning to carry out AI-assisted clinical diagnosis, treatment, and translation of lung cancer.

Objective To propose a framework for risk assessment and stepwise management of pulmonary nodules based on existing guidelines and key studies, and to clarify the boundaries for triage, workup escalation, and referral in different detection scenarios. Methods A problem-oriented evidence synthesis approach was used, prioritizing Chinese expert consensus, Fleischner Society Guidelines, British Thoracic Society (BTS) Guidelines, and Lung-RADS. This was supplemented by studies on risk models, imaging measurements, liquid biopsy, tissue sampling, and surgical treatments. This paper is not presented as a formal consensus or a validated clinical pathway. Results A three-tiered framework consisting of basic non-invasive assessment, advanced assessment, and invasive diagnosis was established. It specified the applicable populations, boundaries for the use of risk models, imaging review, management of conflicting results, evaluation of histopathological consistency, and post-intervention follow-up. Liquid biopsy, genetic testing, and artificial intelligence were defined as investigational or adjunctive tools. Conclusion This framework can serve as a preliminary reference for multidisciplinary teams in developing local protocols. It cannot replace applicable guidelines, pathological diagnosis, shared decision-making with patients, or real-world validation.

Objective:To analyze the results of detection and determinants of thyroid nodules among civil pilots, and to provide evidence for health management and aeromedical support.Methods:The results of health examination and flight data of 2 451 pilots at Xiamen Airlines Co., Ltd. collected between July 1, 2021 and June 30, 2022 was retrospectively analyzed. These pilots were divided into a non-nodule group and a nodule group based on thyroid ultrasound findings. Gender,age, flying hours, body mass index, prevalence of hypertension, blood routine parameters, lipid profiles, liver and kidney function, fasting plasma glucose, and long-haul flight frequency were compared between the 2 groups. Multivariate Logistic regression was performed to identify risk factors for thyroid nodules.Results:Among the 2 397 civil pilots, 2 301 were in the non-nodule group and 96 in the nodule group, with a detection rate of 4.01%. Most of these nodules were solitary and small (<1 cm in diameter, 52.08%), and classified as Chinese Thyroid Imaging Reporting and Data System 3 (likely benign, 53.13%). Detection rates of nodules were significantly higher among clivil pilots of older age or with longer flying hours ( χ2=25.17,36.86,both P<0.001). Overweight/obesity, hypertension, hypertriglyceridemia, hyperuricemia, and frequent long-haul flights were also associated with higher prevalence of thyroid nodules ( χ2=14.81, 6.17, 10.86, 11.57, 4.12, P<0.001,=0.013, 0.001, 0.001,0.042). Multivariate Logistic regression analysis pointed to the following independent risk factors: flying hours of 10 001-15 000 ( OR=4.005, 95% CI: 1.952-8.216) and over 15 000 ( OR=5.220, 95% CI: 2.415-11.285), overweight/obesity ( OR=1.646, 95% CI: 1.052-2.576) and hyperuricaemia ( OR=1.838, 95% CI: 1.204-2.804). Conclusions:The detection rate of thyroid nodules among civil pilots is relatively low. The occurrence is linked to advanced age, hypertension, hypertriglyceridemia and long-haul flight frequency, with cumulative flying hours, overweight/obesity and hyperuricemia as key risk factors. Aviation healthcare providers and medical examiners should provide targeted guidance and interventions related to modifiable risk factors to safeguard clivil pilots′ occupational health.

Radiopharmaceuticals operate by combining radionuclides with carriers. The radiation energy emitted by radionuclides is utilized to selectively irradiate diseased tissues while minimizing damage to healthy tissues. In comparison to external beam radiation therapy, radionuclide drugs demonstrate research potential due to their biological targeting capabilities and reduced normal tissue toxicity. This article reviews the applications and research progress of radiopharmaceuticals in cancer treatment. Several key radionuclides are examined, including ²²³Ra, ⁹⁰Y, Lutetium-177 (¹⁷⁷Lu), ²¹²Pb, and Actinium-225 (²²⁵Ac). It also explores the current development trends of radiopharmaceuticals, encompassing the introduction of novel radionuclides, advancements in imaging technologies, integrated diagnosis and treatment approaches, and equipment-medication combinations. We review the progress in the development of new treatments, such as neutron capture therapy, proton therapy, and heavy ion therapy. Furthermore, we examine the challenges and breakthroughs associated with the clinical translation of radiopharmaceuticals and provide recommendations for the research and development of novel radionuclide drugs.
Humans ; Radiopharmaceuticals/therapeutic use* ; Neoplasms/radiotherapy* ; Radioisotopes/therapeutic use* ; Animals

OBJECTIVE: CRISPR-Cas protects bacteria from exogenous DNA invasion and is associated with bacterial biofilm formation and pathogenicity. METHODS: We analyzed the type I-F CRISPR-Cas system of Legionella pneumophila WX48, including Cas1, Cas2-Cas3, Csy1, Csy2, Csy3, and Cas6f, along with downstream CRISPR arrays. We explored the effects of the CRISPR-Cas system on the in vitro growth, biofilm-forming ability, and pathogenicity of L. pneumophila through constructing gene deletion mutants. RESULTS: The type I-F CRISPR-Cas system did not affect the in vitro growth of wild-type or mutant strains. The biofilm formation and intracellular proliferation of the mutant strains were weaker than those of the wild type owing to the regulation of type IV pili and Dot/Icm type IV secretion systems. In particular, Cas6f deletion strongly inhibited these processes. CONCLUSION The type I-F CRISPR-Cas system may reduce biofilm formation and intracellular proliferation in L. pneumophila.
Legionella pneumophila/pathogenicity* ; CRISPR-Cas Systems ; Biofilms/growth & development* ; Phenotype ; Bacterial Proteins/metabolism* ; Gene Deletion

This article discusses the educational effectiveness of academic associations in colleges and universities under the background of "four new" disciplines. The West China Smart Oral Medicine Association of Sichuan University was taken as an example for practice research to analyze the aspects of community management, student training, ability assessment and reward mechanism, with a focus on the "134" training mode for cultivating the innovation and entrepreneurship abilities among students. This model provides a useful reference for the development of academic associations in colleges and universities, in order to give full play to the educational effectiveness of associations in innovation and entrepreneurship practice and cultivating more outstanding talents for the society.

Objective:To analyze the results of detection and determinants of thyroid nodules among civil pilots, and to provide evidence for health management and aeromedical support.Methods:The results of health examination and flight data of 2 451 pilots at Xiamen Airlines Co., Ltd. collected between July 1, 2021 and June 30, 2022 was retrospectively analyzed. These pilots were divided into a non-nodule group and a nodule group based on thyroid ultrasound findings. Gender,age, flying hours, body mass index, prevalence of hypertension, blood routine parameters, lipid profiles, liver and kidney function, fasting plasma glucose, and long-haul flight frequency were compared between the 2 groups. Multivariate Logistic regression was performed to identify risk factors for thyroid nodules.Results:Among the 2 397 civil pilots, 2 301 were in the non-nodule group and 96 in the nodule group, with a detection rate of 4.01%. Most of these nodules were solitary and small (<1 cm in diameter, 52.08%), and classified as Chinese Thyroid Imaging Reporting and Data System 3 (likely benign, 53.13%). Detection rates of nodules were significantly higher among clivil pilots of older age or with longer flying hours ( χ2=25.17,36.86,both P<0.001). Overweight/obesity, hypertension, hypertriglyceridemia, hyperuricemia, and frequent long-haul flights were also associated with higher prevalence of thyroid nodules ( χ2=14.81, 6.17, 10.86, 11.57, 4.12, P<0.001,=0.013, 0.001, 0.001,0.042). Multivariate Logistic regression analysis pointed to the following independent risk factors: flying hours of 10 001-15 000 ( OR=4.005, 95% CI: 1.952-8.216) and over 15 000 ( OR=5.220, 95% CI: 2.415-11.285), overweight/obesity ( OR=1.646, 95% CI: 1.052-2.576) and hyperuricaemia ( OR=1.838, 95% CI: 1.204-2.804). Conclusions:The detection rate of thyroid nodules among civil pilots is relatively low. The occurrence is linked to advanced age, hypertension, hypertriglyceridemia and long-haul flight frequency, with cumulative flying hours, overweight/obesity and hyperuricemia as key risk factors. Aviation healthcare providers and medical examiners should provide targeted guidance and interventions related to modifiable risk factors to safeguard clivil pilots′ occupational health.

Objective:To investigate the clinical effect of the transfer of lateral femoral fascia or combined with anteriolateral thigh flap (ALTF) on treatment of defects of Achilles tendon and surrounding soft tissue.Methods:From May 2004 to December 2021, 15 patients with Achilles tendons defects were treated with the transfer of either lateral femoral fascia or combined with ALTF in the Department of Hand and Foot Microsurgery, Xi'an Fengcheng Hospital. Two of the patients had postoperative infection after the primary treatment for Achilles tendon rupture and 13 patients had Achilles tendon defect together with various grade of defects of surrounding soft tissues. According to the size of wound, ALTFs and lateral superior knee flaps were used for the reconstructions. Various complex tissue flaps were used in reconstructive surgery: ALTF in 10 patients, the lateral thigh muscular flap in 3 patients and the lateral knee artery flap in 5 patients. The length of Achilles tendon defect was 3.0-8.0 cm and the length of fascia was 4.0-9.0 cm. The sizes of the flaps were 4.0 cm×3.0 cm-30.0 cm×18.0 cm. After the fascia and the flaps were harvested, the fascia was rolled up or wrapped up around the muscle with the knee at 30° flexion and the ankle at 30° flexion. Then end-to-end or end-to-side blood vessel anastomoses were carried out. The ALTFs were used to cover the wounds.Results:All the 15 flaps survived. After 2 to 5 years of follow-up, the heel lift test was found negative, without re-broken of Achilles tendon. All patients were in normal walking gait, except 2 patients who had mild lameness. According to the Amer-Lindholm scoring criteria, the results were excellent in 13 patients and good in 2 patients.Conclusion:Lateral thigh composite tissue transfer is an effective method to reconstruct Achilles tendon and the defects of its surrounding tissues.